Showing results (51-60 of 203) with videos related to

Sort By:
Pageof 21
Journal of the American College of Surgeons|July 7, 2012
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancerKelly L McCoy, Sally E Carty, Michaele J Armstrong, et al.
Surgery|October 9, 2024
Tumor size and molecular risk group are associated with differentiated thyroid cancer recurrenceSaba Kurtom, Jason B Liu, William R Doerfler, et al.
Cancer Cytopathology|August 14, 2012
BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinomaN Paul Ohori, Rashi Singhal, Marina N Nikiforova, et al.
Annals of Surgical Oncology|May 20, 2011
Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancerGina M Howell, Sally E Carty, Michaele J Armstrong, et al.
American Journal of Surgery|May 18, 2012
Immediate laparoscopic adrenalectomy versus observation: cost evaluation for incidental adrenal lesions with atypical imaging characteristicsAdrienne L Melck, Matthew R Rosengart, Michaele J Armstrong, et al.
Endocrine-Related Cancer|May 24, 2022
Clinicopathological features and outcomes of thyroid nodules with EIF1AX mutationsEsra Karslioglu French, Alyaksandr V Nikitski, Linwah Yip, et al.
Endocrine-Related Cancer|July 15, 2021
Can TP53-mutant follicular adenoma be a precursor of anaplastic thyroid carcinoma?Alyaksandr V Nikitski, Marina N Nikiforova, Linwah Yip, et al.
World Journal of Surgery|March 8, 2008
Can a lightbulb sestamibi SPECT accurately predict single-gland disease in sporadic primary hyperparathyroidism?Linwah Yip, Daniel A Pryma, John H Yim, et al.
Thyroid : Official Journal of the American Thyroid Association|March 28, 2023
Molecular Testing Predicts Incomplete Response to Initial Therapy in Differentiated Thyroid Carcinoma Without Lateral Neck or Distant Metastasis at Presentation: Retrospective Cohort StudyJason B Liu, Katherine A Baugh, Kimberly M Ramonell, et al.
Annals of Surgical Oncology|May 4, 2011
MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinomaLinwah Yip, Lindsey Kelly, Yongli Shuai, et al.
Pageof 21